Post-Remission Outcomes in Patients with Acute Myeloid Leukemia (AML) Are Similar between Hypomethylating Agent/Venetoclax Therapy and Intensive Chemotherapy after Accounting for Measurable Residual Disease (MRD) Status
| Autor: | Michael J. Hochman, Alexander J. Ambinder, Lukasz P. Gondek, Amy E. DeZern |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Blood. 140:3387-3388 |
| ISSN: | 1528-0020 0006-4971 |
| DOI: | 10.1182/blood-2022-164757 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|